Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo

Biological properties of new synthetic triindolylmethylium antibiotics of the triindolylmethane group, including compounds containing a maleimide fragment in the structure, are studied. Their high antibacterial activity in vitro, mainly against gram-positive bacteria, but also against strains with m...

Full description

Saved in:
Bibliographic Details
Main Authors: E. P. Mirchink, E. B. Isakova, S. N. Lavrenov, A. Yu. Simonov, V. A. Golibrodo, A. A. Panov, O. P. Bychkova, V. V. Tatarskiy, A. S. Trenin
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/104
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839591305965993984
author E. P. Mirchink
E. B. Isakova
S. N. Lavrenov
A. Yu. Simonov
V. A. Golibrodo
A. A. Panov
O. P. Bychkova
V. V. Tatarskiy
A. S. Trenin
author_facet E. P. Mirchink
E. B. Isakova
S. N. Lavrenov
A. Yu. Simonov
V. A. Golibrodo
A. A. Panov
O. P. Bychkova
V. V. Tatarskiy
A. S. Trenin
author_sort E. P. Mirchink
collection DOAJ
description Biological properties of new synthetic triindolylmethylium antibiotics of the triindolylmethane group, including compounds containing a maleimide fragment in the structure, are studied. Their high antibacterial activity in vitro, mainly against gram-positive bacteria, but also against strains with multiple drug resistance, was shown. The compounds, that showed the least in vitro toxicity on human donor fibroblasts PF-hTERT, were subjected to further testing in animals (mice). The LD50 and LD10 values identified were 24.2 and 16.9 mg/kg, respectively, for LCTA-2701 compound and 41.8 and 34.1 mg/kg for LCTA-2841 compound. In vivo testing of chimeric compounds showed their high efficiency in the model of staphylococcal sepsis in mice and a fairly good tolerability. ED50 values were 1.09 mg/kg for LCTA-2701 compound and 18.27 mg/kg for LCTA-2841 compound, and their chemotherapeutic index was, respectively, 22.2 and 2.3.
format Article
id doaj-art-dda33262d19d4ba4b5b41e4778eea460
institution Matheson Library
issn 0235-2990
language Russian
publishDate 2020-05-01
publisher LLC "Publishing House OKI"
record_format Article
series Антибиотики и Химиотерапия
spelling doaj-art-dda33262d19d4ba4b5b41e4778eea4602025-08-03T13:04:42ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-05-016311-121217103Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivoE. P. Mirchink0E. B. Isakova1S. N. Lavrenov2A. Yu. Simonov3V. A. Golibrodo4A. A. Panov5O. P. Bychkova6V. V. Tatarskiy7A. S. Trenin8Gause Institute of New AntibioticsGause Institute of New AntibioticsGause Institute of New AntibioticsGause Institute of New AntibioticsGause Institute of New AntibioticsGause Institute of New AntibioticsGause Institute of New AntibioticsN. N. Blokhin National Medical Research Centre of OncologyGause Institute of New AntibioticsBiological properties of new synthetic triindolylmethylium antibiotics of the triindolylmethane group, including compounds containing a maleimide fragment in the structure, are studied. Their high antibacterial activity in vitro, mainly against gram-positive bacteria, but also against strains with multiple drug resistance, was shown. The compounds, that showed the least in vitro toxicity on human donor fibroblasts PF-hTERT, were subjected to further testing in animals (mice). The LD50 and LD10 values identified were 24.2 and 16.9 mg/kg, respectively, for LCTA-2701 compound and 41.8 and 34.1 mg/kg for LCTA-2841 compound. In vivo testing of chimeric compounds showed their high efficiency in the model of staphylococcal sepsis in mice and a fairly good tolerability. ED50 values were 1.09 mg/kg for LCTA-2701 compound and 18.27 mg/kg for LCTA-2841 compound, and their chemotherapeutic index was, respectively, 22.2 and 2.3.https://www.antibiotics-chemotherapy.ru/jour/article/view/104triindolylmethanemaleimidechimeric (hybrid) antibioticsantibacterial and antifungal activity in vitro and in vivocytotoxicityin vivo toxicityefficacy in a model of staphylococcal sepsis in mice
spellingShingle E. P. Mirchink
E. B. Isakova
S. N. Lavrenov
A. Yu. Simonov
V. A. Golibrodo
A. A. Panov
O. P. Bychkova
V. V. Tatarskiy
A. S. Trenin
Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
Антибиотики и Химиотерапия
triindolylmethane
maleimide
chimeric (hybrid) antibiotics
antibacterial and antifungal activity in vitro and in vivo
cytotoxicity
in vivo toxicity
efficacy in a model of staphylococcal sepsis in mice
title Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
title_full Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
title_fullStr Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
title_full_unstemmed Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
title_short Study of the Activity and Toxicity of New Antibacterial Agents Based on Triindolylmethane Derivatives in vivo
title_sort study of the activity and toxicity of new antibacterial agents based on triindolylmethane derivatives in vivo
topic triindolylmethane
maleimide
chimeric (hybrid) antibiotics
antibacterial and antifungal activity in vitro and in vivo
cytotoxicity
in vivo toxicity
efficacy in a model of staphylococcal sepsis in mice
url https://www.antibiotics-chemotherapy.ru/jour/article/view/104
work_keys_str_mv AT epmirchink studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT ebisakova studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT snlavrenov studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT ayusimonov studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT vagolibrodo studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT aapanov studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT opbychkova studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT vvtatarskiy studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo
AT astrenin studyoftheactivityandtoxicityofnewantibacterialagentsbasedontriindolylmethanederivativesinvivo